Navigation Links
Diabetes Drug Avandia Ups Heart Risk, Reviews Conclude
Date:6/29/2010

By Amanda Gardner
HealthDay Reporter

MONDAY, June 28 (HealthDay News) -- According to data pooled from several large clinical trials, the diabetes drug Avandia does raise the odds of having a heart attack, bolstering the argument that the drug's risks might outweigh its benefits in people with type 2 diabetes.

Avandia did not, however, show an increased risk for death from cardiovascular disease, said the authors of a meta-analysis appearing in the June 28 online issue of the Archives of Internal Medicine.

A second study, this one appearing in a companion publication, the June 28 online issue of the Journal of the American Medical Association (JAMA), found that, in patients over the age of 65, taking rosiglitazone (Avandia) carried a higher risk for stroke, heart failure and all-cause death when compared to a similar medication known as pioglitazone (Actos).

Both papers are being published online in advance of a U.S. Food and Drug Administration advisory panel that is set to convene in July to recommend the fate of this best-selling medication.

Whether or not these new results will sway the committee remains to be seen.

"I think it's pretty compelling scientifically to have both of these studies in advance of the FDA advisory panel meeting, but advisory panels have been very reluctant to take drugs off the market," said Dr. Steve Nissen, lead author of the Archives analysis and chair of the department of cardiovascular medicine at The Cleveland Clinic. "And it's very hard for clinicians who are used to using drugs to say they've been doing the wrong thing. Clinical inertia is a very big problem in medicine."

According to background information in the study, Nissen has received payments from various pharmaceutical companies but has contributed all the monies to charity.

Dr. Kirk Garratt, clinical director of interventional cardiovascular research at Lenox Hill Hos
'/>"/>

Copyright©2010 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3 4

Related medicine news :

1. Gestational Diabetes Linked to Serotonin and Dietary Protein
2. Mass. General Hospital, Iacocca Foundation announce completion of Phase I diabetes trial
3. Healthier cafeteria food, more intense gym classes lower students diabetes risk
4. Intervention lowered obesity rate in youth at high diabetes risk, HEALTHY study finds
5. More Genes Implicated in Type 2 Diabetes
6. Can too much HDL be harmful to women with type 1 diabetes?
7. Minor kidney damage in people with type 1 diabetes leads to increased mortality
8. Diabetes May Double Risk of Heart Attack, Stroke
9. Drug Helps Tackle Type 2 Diabetes in New Way, Study Says
10. Gaining Weight Later in Life Ups Diabetes Risk
11. Diabetes patients admitted for acute exacerbations of COPD have longer hospital stay
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Diabetes Drug Avandia Ups Heart Risk, Reviews Conclude
(Date:12/24/2014)... Dr. Ronald Receveur, a New ... dental implants in a day, has written ... overusing teeth-whitening treatments. , In his blog published ... Receveur writes that overusing teeth-whitening treatments can lead to ... enamel. , “Because teeth-whitening treatments are available ...
(Date:12/24/2014)... News) -- Longer and colder body cooling does not reduce ... from a lack of oxygen, a new study finds. ... condition -- called hypoxic ischemic encephalopathy -- can be reduced ... Fahrenheit) for 72 hours, experts say. Research has shown ... so this study examined if the same would be true ...
(Date:12/22/2014)... December 22, 2014 B. E. Smith, ... healthcare providers, has been retained to lead a national ... Medical Center in Oceanside, Calif. The top ... E. Smith has recently placed more than 900 healthcare ... a community owned, 397-bed, Gold Seal-approved, full-service acute-care hospital ...
(Date:12/22/2014)... 22, 2014 Sagacious Consultants, the premier ... subscription option to their ad hoc report writing service ... Customers can sign up for an annual subscription and ... month at a deeply discounted hourly rate. , ... has a progressively discounted rate. Subscription hours are contracted ...
(Date:12/22/2014)... News) -- U.S. and state health officials are investigating ... killed at least four people and sickened 28 others ... commercially produced, prepackaged caramel apples until more information becomes ... said in a news release. As of Dec. ... with the outbreak strains of the bacteria Listeria ...
Breaking Medicine News(10 mins):Health News:New Albany Dentist Weighs In On New Trend of Overbleaching Teeth 2Health News:New Albany Dentist Weighs In On New Trend of Overbleaching Teeth 3Health News:Greater Cooling of Oxygen-Deprived Infants Fails to Improve Survival 2Health News:Tri-City Medical Center Retains B. E. Smith to Recruit New Chief Compliance Officer 2Health News:Tri-City Medical Center Retains B. E. Smith to Recruit New Chief Compliance Officer 3Health News:Sagacious Consultants’ New Subscription Packages Offer Customers Additional Report Writing Options 2Health News:Sagacious Consultants’ New Subscription Packages Offer Customers Additional Report Writing Options 3Health News:CDC Warns of Listeria Danger From Caramel Apples 2
... SANTA MONICA, Calif., June 11 Cord Blood America, ... umbilical cord blood stem cell preservation companies ( ... life saving potential of stem cells to families nationwide ... for sales operation expansion into the European Union, specifically ...
... ... Appliance (CMA) and AMD ADEN™ Solution Offers laptop and desktop-based telehealth capabilities anywhere, ... ... the global leader in telepresence, video, and voice communications solutions, and AMD Global ...
... ... ISBN-10: 1420058959, 592 pages) with a complete CD-ROM by Perry Hookman MD can be ... ... all practicing physicians are sued annually for malpractice. Nurses, pharmacists and other healthcare professionals ...
... ... Hormonal health is a struggle for women of all ages. Despite the ... something non-synthetic for symptomatic relief of menstrual and menopausal woes. Garden of ... is providing women of all ages a natural way to balance hormones ...
... , WASHINGTON, June 11 On Wednesday the U.S. ... the Foreign Relations Reauthorization Act, which creates a new ... office coordinate and support efforts regarding "women,s empowerment" around ... testified before the Foreign Affairs Committee that this administration ...
... Allscripts announced today that its 3.50 percent Convertible ... at the option of the holders of the Debentures ... August 31, 2009. Any determinations regarding the convertibility ... in accordance with the terms of the indenture under ...
Cached Medicine News:Health News:Cord Blood America Continuing European Expansion 2Health News:Polycom and AMD Global Telemedicine Inc. To Deliver Integrated Visual And Voice Telehealth Capability To Clinicians On-The-Go 2Health News:Polycom and AMD Global Telemedicine Inc. To Deliver Integrated Visual And Voice Telehealth Capability To Clinicians On-The-Go 3Health News:Want to Learn How to Testify? New Home Study Course by Practicing Physician Teaches Medical Malpractice Defendants and Physicians How to be Effective in Court 2Health News:Want to Learn How to Testify? New Home Study Course by Practicing Physician Teaches Medical Malpractice Defendants and Physicians How to be Effective in Court 3Health News:MORE WOMEN SHUN HORMONE REPLACEMENT THERAPY Garden of Life Offers a Natural Solution with Oceans 3™ Healthy Hormones™ 2Health News:MORE WOMEN SHUN HORMONE REPLACEMENT THERAPY Garden of Life Offers a Natural Solution with Oceans 3™ Healthy Hormones™ 3Health News:MORE WOMEN SHUN HORMONE REPLACEMENT THERAPY Garden of Life Offers a Natural Solution with Oceans 3™ Healthy Hormones™ 4Health News:Allscripts Announces Convertibility of its Outstanding 3.50 Percent Senior Debentures 2Health News:Allscripts Announces Convertibility of its Outstanding 3.50 Percent Senior Debentures 3Health News:Allscripts Announces Convertibility of its Outstanding 3.50 Percent Senior Debentures 4
(Date:12/22/2014)... PALO ALTO, Calif. , Dec, 22, 2014 ... of a Phase 2a study of lonafarnib in ...  The study was conducted at the National Institutes ... Bethesda, Maryland .  The double-blinded, randomized, placebo-controlled, ... 100 mg twice daily and 200 mg twice ...
(Date:12/22/2014)... TWi Biotechnology, Inc., today announced that ... TWi Biotechnology,s lead drug candidate, from The State ... for patent application numbered 201180018154.8.  This patent ... metabolite for treatment of type II diabetes.  The ... AC-201 for type II diabetes, and provides a ...
(Date:12/19/2014)...  Newport Corporation (NASDAQ: NEWP ) ... the company,s Board of Directors.  Dr. Kadia is ... of Evans Analytical Group, a leading global provider ... to companies in a wide range of industries.   ... Group, Dr. Kadia spent nine years with Life ...
Breaking Medicine Technology:Eiger Bio Announces Positive Data in Patients Infected with Hepatitis Delta Virus (HDV) Treated with Lonafarnib - Results Presented at American Association for the Study of Liver Diseases (AASLD) Meeting 2Eiger Bio Announces Positive Data in Patients Infected with Hepatitis Delta Virus (HDV) Treated with Lonafarnib - Results Presented at American Association for the Study of Liver Diseases (AASLD) Meeting 3TWi Biotechnology Receives Notice of Patent Allowance for Its Lead Drug Candidate AC-201 for the Indication of Type II Diabetes in China 2TWi Biotechnology Receives Notice of Patent Allowance for Its Lead Drug Candidate AC-201 for the Indication of Type II Diabetes in China 3Siddhartha Kadia, Ph.D. Joins Board of Directors of Newport Corporation 2
... 2010 CareFusion (NYSE: ... today launched the EnVe™ ventilator , a ... 70-80 pounds lighter than other ventilators with similar ... The EnVe ventilator has the capability to ...
... Dec. 20, 2010 Codexis, Inc. (Nasdaq: CDXS ... Jaffray Clean Technology & Renewables Conference, to be held in ... be made by Robert Lawson, Senior Vice President and Chief ... noon Eastern Time.  A webcast and replay will be available ...
Cached Medicine Technology:CareFusion Launches EnVe Ventilator, Weighing 10 Times Less Than Traditional Critical Care Ventilators 2CareFusion Launches EnVe Ventilator, Weighing 10 Times Less Than Traditional Critical Care Ventilators 3
For the quantitative determination of total cholesterol in serum....
Intended for the quantitative determination of total cholesterol in serum. Single vial, dry powder reagent. Reaction: Endpoint. Wavelength: 500 nm. Linearity: 700 mg/dL (12.9 mmol/L)....
This 16-bit integrated and cooled system is a completely self contained unit built with a long list of standard features including all-electronic-variable transilluminator and EPI lighting....
... new dedicated high performance bio imaging system ... process of imaging chemiluminescent samples. It provides ... to use, thanks to new, unique image ... on the standard Genegnome, the Genegnome HR ...
Medicine Products: